Anebulo shareholders approve authorized share increase to 75M and board declassification

Anebulo Pharmaceuticals, Inc.

Stockholders approved raising authorized common shares from 50M to 75M at the April 4, 2025 Annual Meeting.
Certificates of amendment filed with Delaware on April 11, 2025.
Stockholders also approved declassification of the Board; all directors will stand for annual election starting next meeting.
Board adopted conforming Bylaws amendment effective upon the declassification charter amendment.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.